Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-BENZHYDRYL-1H-IMIDAZOLE is an organic compound characterized by the molecular formula C15H16N2. It is a heterocyclic compound that features an imidazole ring fused with a benzhydryl group. This unique structure positions 1-BENZHYDRYL-1H-IMIDAZOLE as a versatile building block in the synthesis of various heterocyclic compounds and pharmaceuticals. Its potential applications span across anti-inflammatory and antifungal properties, as well as its role in metal ion binding and metalloenzyme inhibition, making it a promising candidate for research and development in medicinal chemistry.

7189-67-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 7189-67-5 Structure
  • Basic information

    1. Product Name: 1-BENZHYDRYL-1H-IMIDAZOLE
    2. Synonyms: 1-BENZHYDRYL-1H-IMIDAZOLE
    3. CAS NO:7189-67-5
    4. Molecular Formula: C16H14N2
    5. Molecular Weight: 234.2958
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 7189-67-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 383.4°Cat760mmHg
    3. Flash Point: 185.7°C
    4. Appearance: /
    5. Density: 1.06g/cm3
    6. Vapor Pressure: 9.71E-06mmHg at 25°C
    7. Refractive Index: 1.603
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 1-BENZHYDRYL-1H-IMIDAZOLE(CAS DataBase Reference)
    11. NIST Chemistry Reference: 1-BENZHYDRYL-1H-IMIDAZOLE(7189-67-5)
    12. EPA Substance Registry System: 1-BENZHYDRYL-1H-IMIDAZOLE(7189-67-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 7189-67-5(Hazardous Substances Data)

7189-67-5 Usage

Uses

Used in Organic Synthesis:
1-BENZHYDRYL-1H-IMIDAZOLE is used as a building block in the synthesis of heterocyclic compounds and pharmaceuticals. Its unique structure allows for the creation of a wide range of complex organic molecules that can be utilized in various applications within the pharmaceutical industry.
Used in Medicinal Chemistry:
1-BENZHYDRYL-1H-IMIDAZOLE is used as a potential anti-inflammatory agent, offering a new avenue for the development of treatments targeting inflammation-related conditions. Its anti-inflammatory properties could be harnessed to alleviate symptoms and improve patient outcomes.
Used in Antifungal Applications:
1-BENZHYDRYL-1H-IMIDAZOLE is also being studied for its antifungal capabilities, which could lead to the development of new antifungal drugs. This is particularly important in the context of increasing antibiotic resistance and the need for novel treatments to combat fungal infections.
Used in Metal Ion Binding and Metalloenzyme Inhibition:
1-BENZHYDRYL-1H-IMIDAZOLE has been investigated for its role in metal ion binding and the inhibition of metalloenzymes. This property can be significant in the development of drugs that target specific metal-dependent biological processes, potentially leading to treatments for various diseases where metalloenzymes play a crucial role.
Overall, 1-BENZHYDRYL-1H-IMIDAZOLE's diverse potential applications in medicinal chemistry and drug development highlight its importance as a compound of interest for future research and pharmaceutical innovation.

Check Digit Verification of cas no

The CAS Registry Mumber 7189-67-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,8 and 9 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 7189-67:
(6*7)+(5*1)+(4*8)+(3*9)+(2*6)+(1*7)=125
125 % 10 = 5
So 7189-67-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H14N2/c1-3-7-14(8-4-1)16(18-12-11-17-13-18)15-9-5-2-6-10-15/h1-13,16H

7189-67-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzhydrylimidazole

1.2 Other means of identification

Product number -
Other names 1-diphenylmethaneimidazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7189-67-5 SDS

7189-67-5Relevant articles and documents

Polynuclear Ag(I)-N-heterocyclic carbene complexes: synthesis, electrochemical and in vitro anticancer study against human breast cancer and colon cancer

Habib, Aqsa,Iqbal, Muhammad Adnan,Bhatti, Haq Nawaz

, p. 2065 - 2079 (2019)

Four new bis-imidazolium salts 3–6 and their di- and polynuclear silver(I)–N-heterocyclic carbene (Ag(I)–NHC) complexes 7–10 were synthesized and characterized by using various analytical techniques. Single-crystal studies of 8 revealed a dinuclear struct

Synthesis and biological evaluation of 1‐(Diarylmethyl)‐1h‐1,2,4‐triazoles and 1‐(diarylmethyl)‐1h‐imidazoles as a novel class of anti‐mitotic agent for activity in breast cancer

Ana, Gloria,Kelly, Patrick M.,Malebari, Azizah M.,Noorani, Sara,Nathwani, Seema M.,Twamley, Brendan,Fayne, Darren,O’boyle, Niamh M.,Zisterer, Daniela M.,Pimentel, Elisangela Flavia,Endringer, Denise Coutinho,Meegan, Mary J.

, p. 1 - 59 (2021/03/16)

We report the synthesis and biochemical evaluation of compounds that are designed as hybrids of the microtubule targeting benzophenone phenstatin and the aromatase inhibitor letrozole. A preliminary screening in estrogen receptor (ER)‐positive MCF‐7 breast cancer cells identified 5‐((2H‐1,2,3‐triazol‐1‐yl)(3,4,5‐trimethoxyphenyl)methyl)‐2‐methoxyphenol 24 as a potent antiproliferative compound with an IC50 value of 52 nM in MCF‐7 breast cancer cells (ER+/PR+) and 74 nM in triple‐negative MDA‐MB‐231 breast cancer cells. The compounds demonstrated significant G2/M phase cell cycle arrest and induction of apoptosis in the MCF‐7 cell line, inhibited tubulin polymerisation, and were selective for cancer cells when evaluated in non-tumorigenic MCF‐10A breast cells. The immunofluorescence staining of MCF‐7 cells confirmed that the compounds targeted tubulin and induced multinucleation, which is a recognised sign of mitotic catastrophe. Computational docking studies of compounds 19e, 21l, and 24 in the colchicine binding site of tubulin indicated potential binding conformations for the compounds. Compounds 19e and 21l were also shown to selectively inhibit aromatase. These compounds are promising candidates for development as antiproliferative, aromatase inhibitory, and microtubule‐disrupting agents for breast cancer.

Stable group 8 metal porphyrin mono- And bis(dialkylcarbene) complexes: Synthesis, characterization, and catalytic activity

Che, Chi-Ming,Huang, Jie-Sheng,Low, Kam-Hung,Wan, Qingyun,Wang, Hai-Xu,Zhang, Jun-Long,Zhou, Cong-Ying

, p. 2243 - 2259 (2020/03/11)

Alkyl-substituted carbene (CHR or CR2, R = alkyl) complexes have been extensively studied for alkylcarbene (CHR) ligands coordinated with high-valent early transition metal ions (a.k.a. Schrock carbenes or alkylidenes), yet dialkylcarbene (CR2) complexes remain less developed with bis(dialkylcarbene) species being little (if at all) explored. Herein, several group 8 metal porphyrin dialkylcarbene complexes, including Fe- and Ru-mono(dialkylcarbene) complexes [M(Por)(Ad)] (1a,b, M = Fe, Por = porphyrinato dianion, Ad = 2-adamantylidene; 2a,b, M = Ru) and Os-bis(dialkylcarbene) complexes [Os(Por)(Ad)2] (3a-c), are synthesized and crystallographically characterized. Detailed investigations into their electronic structures reveal that these complexes are formally low-valent M(ii)-carbene in nature. These complexes display remarkable thermal stability and chemical inertness, which are rationalized by a synergistic effect of strong metal-carbene covalency, hyperconjugation, and a rigid diamondoid carbene skeleton. Various spectroscopic techniques and DFT calculations suggest that the dialkylcarbene Ad ligand is unique compared to other common carbene ligands as it acts as both a potent σ-donor and π-acceptor; its unique electronic and structural features, together with the steric effect of the porphyrin macrocycle, make its Fe porphyrin complex 1a an active and robust catalyst for intermolecular diarylcarbene transfer reactions including cyclopropanation (up to 90% yield) and X-H (X = S, N, O, C) insertion (up to 99% yield) reactions.

Design, synthesis and antifungal activity of some new imidazole and triazole derivatives

Rezaei, Zahra,Khabnadideh, Soghra,Zomorodian, Kamiar,Pakshir, Kyvan,Kashi, Giti,Sanagoei, Narges,Gholami, Sanaz

experimental part, p. 658 - 665 (2012/06/29)

Triazole and imidazole are incorporated into the structures of many antifungal compounds. In this study a novel series of 1,2,4-triazole, imidazole, benzoimidazole, and benzotriazole derivatives was designed as inhibitors of cytochrome P450 14α-demethylase (14DM). These structures were docked into the active site of MT-CYP51, using Autodock program. Sixteen compounds with the best binding energy were synthesized. The chemical structures of the new compounds were confirmed by elemental and spectral (1H-NMR and Mass) analyses. All compounds were investigated for antifungal activity against Candida albicans, Candida tropicalis, Candida glabrata, Candida parapeilosis, Candida kruzei, Candida dubliniensis, Aspergillus fomigatus, Aspergillus flavus, Microsporum canis, Microsporum gypseum, Trichophyton mentagrophyte, Epidermophyton floccosum. Some compounds showed excellent in-vitro antifungal activity against most of the tested fungi. Compounds 2, 9, and 10 had antifungal activity against several resistant fungi against fluconazole and itraconazole. A novel series of azole derivatives was designed and synthesized as inhibitors of cytochrome P450 14α-demethylase and the compounds were investigated for antifungal activity. Copyright

Synthesis, antibacterial and antifungal activities of bifonazole derivatives

El Hage, Salome,Lajoie, Barbora,Feuillolay, Catherine,Roques, Christine,Baziard, Genevieve

experimental part, p. 402 - 410 (2012/01/11)

Two series of chlorinated benzhydryl imidazole and triazole derivatives were synthesized and tested in vitro against representative strains of potent pathogenic bacteria (Staphylococcus aureus CIP 4.83, Escherichia hirae CIP 5855, Pseudomonas aeruginosa CIP 82118, Escherichia coli CIP 53126) and fungi (Aspergillus niger IP 1431.83, Candida albicans IP 48.72, Candida krusei IP 208.52, Trichophython rubrum IP 1657.86). Most of these compounds were devoid of any antimicrobial activity, but several of them inhibited T. rubrum with MIC values in the range of 0.125 to 32 μg/mL, similar or superior to those of bifonazole and clotrimazole, used as standard controls. The replacement of the imidazole ring with a triazole moiety in these compounds led to derivatives with less antifungal activity. A preliminary SAR was undertaken on the effect of the number and the position of chlorine atoms on the distribution of negative charge on the surface of some compounds on antifungal activity. Copyright

Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors

Doiron, Jeremie,Soultan, Al Haliffa,Richard, Ryan,Toure, Mamadou Mansour,Picot, Nadia,Richard, Remi,Cuperlovic-Culf, Miroslava,Robichaud, Gilles A.,Touaibia, Mohamed

experimental part, p. 4010 - 4024 (2011/10/30)

A series of bis- and mono-benzonitrile or phenyl analogues of letrozole 1, bearing (1,2,3 and 1,2,5)-triazole or imidazole, were synthesized and screened for their anti-aromatase activities. The unsubstituted 1,2,3-triazole 10a derivative displayed inhibitory activity comparable with that of the aromatase inhibitor, letrozole 1. Compound 10a, bearing a 1,2,3-triazole, is also 10000-times more tightly binding than the corresponding analogue 25 bearing a 1,2,5-triazole, which confirms the importance of a nitrogen atom at position 3 or 4 of the 5-membered ring needed for high activity. The effect on human epithelial adrenocortical carcinoma cell line (H295R) proliferation was also evaluated. The compound 10j (IC50 = 4.64 μM), a letrozole 1 analogue bearing para-cyanophenoxymethylene-1,2,3-triazole decreased proliferation rates of H295R cells by 76 and 99% in 24 and 72 h respectively. Computer calculations, using quantum ab initio structures, suggest a possible correlation between anti-aromatase activity and the distance between the nitrogen in position 3 or 4 of triazole nitrogen and the cyano group nitrogen.

LuxR dependent quorum sensing inhibition by N,N′-disubstituted imidazolium salts

Sabbah, Mohamad,Soulre, Laurent,Reverchon, Sylvie,Queneau, Yves,Doutheau, Alain

scheme or table, p. 4868 - 4875 (2011/09/21)

Thirty N,N′-disubstituted imidazolium salts have been synthesized and evaluated as LuxR antagonists. Substitution on one of the imidazolium nitrogen atoms includes benzhydryl, fluorenyl or cyclopentyl substituent, and alkyl chains of various lengths on th

The reaction of carbonyldiimidazole with alcohols to form carbamates and N-alkylimidazoles

Tang, Yuanqing,Dong, Yuxiang,Vennerstrom, Jonathan L.

, p. 2540 - 2544 (2007/10/03)

The reactions of non-benzylic primary and secondary aliphatic alcohols with carbonyldiimidazole (CDI) afford the corresponding carbamates but not N-alkylimidazoles. For benzylic primary alcohols, formation of N-alkylimidazoles proceeds reasonably at 170 °C in several different solvents and occurs by way of the initially formed carbamate. However, under these rather forcing conditions, or even at lower reaction temperatures, elimination is a significant side reaction for benzylic secondary alcohols with β-hydrogen atoms. With one exception, reactions of six N,N-disubstituted β-aminoalcohols with CDI to form N-alkylimidazoles proceed under relatively mild conditions and may occur by way of an aziridinium intermediate.

Optically active iridium imidazol-2-ylidene-oxazoline complexes: Preparation and use in asymmetric hydrogenation of arylalkenes

Perry, Marc C.,Cui, Xiuhua,Powell, Mark T.,Hou, Duen-Ren,Reibenspies, Joseph H.,Burgess, Kevin

, p. 113 - 123 (2007/10/03)

This work explores the potential of iridium complexes of the N-heterocyclic carbene oxazoline ligands 1 in asymmetric hydrogenations of arylalkenes. The accessible carbene precursors, imidazolium salts 2, and robust iridium complexes 5 facilitated a disco

Open-chain dications and betaines with imidazolium molecular motifs: Synthesis and structural aspects

Alcalde, Ermitas,Mesquida, Neus,Alemany, Montserrat,Alvarez-Rua, Carmen,Garcia-Granda, Santiago,Pacheco, Pedro,Perez-Garcia, Lluisa

, p. 1221 - 1231 (2007/10/03)

The synthesis of trinuclear open-chain prototypes gave variable yields: > 53% for dications 1·2X and 2·2X and > 80% for proton-ionizable dications 3·2X-5·2X incorporating 1H-1,2,4-triazole moieties. Deprotonation of the latter compounds resulted in the formation of the betaine counterparts 13·X-15·X. The courses of the dequaternization reactions of compounds 4·2X and 5·2X were also studied. The structural properties of dicationic protophanes 1·2X and 2·2X, containing bis(imidazolium) motifs, were examined by 1H and 13C NMR spectroscopy, electrospray mass spectrometry and by single-crystal X-ray diffraction analysis of the dication 1b·2PF6. Weak noncovalent interactions between the dications and the hexafluorophosphate ions bias the protophane conformation both in solution and in the solid state. X-ray diffraction reveals that the PF6- counterions are located in a channel formed by the dications (1b2+). Wiley-VCH Verlag GmbH, 69451 Weinheim, Germany, 2002.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7189-67-5